Drug intelligence / Profile preview

2% chlorhexidine gluconate-impregnated washcloths

Development stage
Unknown
Lead developer
Sage Products
Modality
Small Molecules
Administration
Topical
01

Overview

2% chlorhexidine gluconate-impregnated washcloths are a topical antiseptic intervention used for daily bathing to reduce the incidence of methicillin-resistant Staphylococcus aureus (MRSA) colonization in healthcare settings. Chlorhexidine gluconate (CHG) is a broad-spectrum biguanide antiseptic that acts by binding to the negatively charged bacterial cell wall and disrupting the cytoplasmic membrane, leading to the leakage of intracellular components and subsequent cell death. In a cluster-randomized controlled trial conducted at Baycrest Health Sciences, this protocol was evaluated in complex continuing care patients to prevent the acquisition of MRSA. While the intervention demonstrated a 71% reduction in MRSA colonization incidence in the study group, the results did not reach statistical significance due to low event numbers. This intervention is considered a combination of a pharmaceutical antiseptic agent and a medical device delivery system.

Other names
CHG antiseptic body cleanser2% CHG-impregnated antiseptic washclothsCHG bathing protocol
02

Targets

Bacterial cell membrane phospholipids and negatively charged cell surface components

Beyond the preview

Go deeper on 2% chlorhexidine gluconate-impregnated washcloths.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2% chlorhexidine gluconate-impregnated washcloths.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call